Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation

Pei‐Ling Hsieh(China Medical University), Shih‐Hung Chan(National Cheng Kung University Hospital)
International Journal of Molecular Sciences
September 4, 2022
Cited by 109


Related Papers